Study conducted to see the effect of Ayurvedic Formulation as an add-on drug to evaluate lipid profile and ecg changes in the Ischemic Heart Disease

Evaluation of Ayurvedic Formulation as an add-on drug in the Ishemic Heart Disease with special reference to Vataj Hridrog - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/02/080255

Enrollment

Registered

2025-02-10

Start date

Unknown

Completion date

Unknown

Last updated

2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I00-I99- Diseases of the circulatory system

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patient who were pre-diagnosed with Ischemic Heart Disease Vataj Hridrog presenting classical sign and symptoms as Precordial pain (Hridshool including all type of chest pain) Dyspnoea (Shwasavrodha) Palpitation(Hrutdrav) Fatigue(Akasmat dinata) Any two ECG-ST-Tchanges ST depressionand T wave inversion in anterior wall,lateral,posterior,inferior,septal wall.

Exclusion criteria

Exclusion criteria: Acute Myocardial Infraction Unstable Angina Pregnant and lactation mother Known history of hemorrhagic storke Known history of Positive HIV test Hepatitis B surface antigen Any other chronic disease

Design outcomes

Primary

Measure	Time frame
To assess the Add On effect of Ayurvedic Formulation on Precordial pain (Hridshool including all type chest pain) Dyspnoea(Shwasavrodha) Palpitation (Hrutdrav) Ftigue (Akasmat dinata)Timepoint: 30 Days study with follow up (15,30)	—

Secondary

Measure	Time frame
To assess improvement in ECG-ST-T changes (ST- depression,T wave inversion)Timepoint: 30 Days study with follow up (15,30)	—

Countries

India

Contacts

Public ContactDr Shweta Patil

Dr D Y Patil College of Ayurved and Research centre

abhijitshekhar00@gmail.com9764546495

Outcome results